Secondary Logo

Journal Logo

Advanced Search

Video Gallery

Uterine Fibroids in Menopause and Perimenopause

Video Author: Paige Wynne
Video Production Specialist
Creative and Digital Services
University of Illinois at Chicago
Published on: 01.22.2020
Associated with: February 2020, Volume 27, Issue 2; Menopause. 27(2):238-242, February 2020

In this video, we glimpse the significance of Uterine fibroid disease and highlights their unusual persistence in menopause women. Moreover, we discuss the possible available treatment options as well as the advantages and disadvantages of using hormonal therapy in this specific population.

Related Videos

All Videos
Most Viewed
Most Emailed



Video Summary for Grandi G et al.2020
Creator: No sponsor
Duration: 3:10
Satisfaction with RRSO in BRCA mutation carriers
Play Video | + Favorites
Early Menopause, High Sensitivity Cardiac Troponin T and Heart Failure Risk
Creator: Aniekan Akpaffiong
Duration: 1:30
Early menopause, Troponin and Heart Failure
Play Video | + Favorites
HDL-C and arterial calcification in midlife women: The contribution of estradiol and C-reactive protein
Creator: Gretchen Swabe
Duration: 3:05
This video is a brief summary of our research investigating how estradiol relates to the association of HDL-C on arterial calcification risk in midlife women in the Study of Women’s Health Across the Nation.
Play Video | + Favorites
Sexual Function and Menopause Transition
Creator: Krzysztof Nowosielski
Duration: 6:25
The video presents the results on the study on body image, sexual function, sexual problems and sexual dysfunction in women between 45 and 55 years old, who use menopausal hormonal therapy in comparison with non-users.
Play Video | + Favorites
The impact of frailty in older women undergoing pelvic floor reconstructive surgery
Creator: Dr. Jonathan Shaw
Duration: 4:12
A short video introduction to pre-operative frailty screening in post-menopausal women
Play Video | + Favorites
Efficacy of progesterone-only treatment for the management of menopausal symptoms: A systematic review
Creator: Sarah Sheehan Stadler, MD
Duration: 3:51
Review of literature regarding progesterone only for the management of menopausal symptoms
Play Video | + Favorites
The ewe as an animal model of vaginal atrophy and vaginal Er:YAG laser application
Creator: Martin Hájek
Duration: 3:46
In sheep of reproductive age, we aimed to document decrease in epithelial thickness, glycogen amount and other vaginal changes after castration and the effect of Er:YAG laser as used clinically.
Play Video | + Favorites
Age associated trends of vulvar cancer in the U.S.
Creator: Hanaa Khadraoui, MS-IV
Duration: 4:59
In this video, we present our study “Age associated trends of vulvar cancer in the U.S.” We discuss the purpose behind our study, describe our methods and noteworthy results, as well as review the importance of our findings with regards to the care of post-menopausal and older women.
Play Video | + Favorites
The role and value of a nationwide toll-free consultation hotline for menopause-related issues
Creator: Pei-Shan Lee and Chyi-Long Lee
Duration: 2:44
Women may experience different degrees of symptoms before, during, and after menopause. We investigate the prevalence of symptoms and associated factors in Taiwanese women calling a menopause hotline. This hotline enables women to consult others regarding menopause-related issues through phone calls without having to take time off to visit a hospital. The role and value of a "nationwide toll-free consultation hotline for menopause-related issues" is a concept that deserves wider consideration and utilization around the world.
Play Video | + Favorites
Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 25 women treated with 10 μg estradiol vaginal tablets
Creator: Dr Christine M. Derzko / Novo Nordisk
Duration: 5:57
Dr Christine M. Derzko outlines the rationale, methods, and results of a study that investigates if there is a relationship between a postmenopausal woman’s age and her response to vaginal estrogen treatment prescribed for vaginal atrophy.

Dr Derzko is an Associate Professor at the Department of Obstetrics & Gynecology and Department of Internal Medicine (Endocrinology Division) at the University of Toronto, Canada. Dr Derzko also works as a physician at St. Michael’s Hospital in Toronto, Canada.
Play Video | + Favorites
Applying the MAUDE Database for Novel Technologies in Gynecology: Characterization of adverse events of vaginal energy-based devices
Creator: Shannon Leigh Wallace
Duration: 5:24
This video describes how our group at Stanford accessed the publicly available MAUDE database to characterize the adverse events reports of vaginal energy-based devices. In this video we discuss the recent FDA announcement released on July 30, 2018 regarding vaginal energy-based devices.
Play Video | + Favorites
Behavioral and psychological health inequities in income disparate perimenopausal women
Creator: Kirsten Dickins
Duration: 4:33
Kirsten Dickins, Postdoctoral Research Fellow at the Yvonne L. Munn Center for Nursing Research at Massachusetts General Hospital discusses findings from her brief report: “Behavioral and psychological health inequities in income disparate perimenopausal women”, which describes stark differences between income disparate and non-income disparate perimenopausal women in behavioral health (smoking, substance use history, BMI, exercise) and psychological health characteristics (depressed mood, anxiety, sleep). Next directions for clinicians and researchers invested in addressing disparities in peri- and postmenopausal women are discussed.
Play Video | + Favorites
Video summary: “Onset of the climacteric phase by the mid-forties associated with impaired insulin sensitivity: a birth cohort study”.
Creator: Susanna Savukoski
Duration: 3:54
Video summary of article “Onset of the climacteric phase by the mid-forties associated with impaired insulin sensitivity: a birth cohort study”, in which MD Susanna Savukoski tells about the study setting, its background and clinical importance.
Play Video | + Favorites
Age at menarche and Cardiovascular Health
Creator: Yi Zheng
Duration: 5:22
Age at menarche is predictive of cardiovascular health among young women, which may be used to identify high-risk population and guide targeted interventions to maintain and improve women’s cardiovascular health.
Play Video | + Favorites
Acupuncture ameliorated vasomotor symptoms during menopausal transition: single-blind, placebo-controlled, randomized trial to test treatment efficacy.
Creator: José Maria Soares Júnior
Duration: 6:30
1) Introduction and Significance of manuscript; 2) Innovation of study; 3) Clinical application; 4) Strengths and limitations; 5) Application of technique on the diary practice; 6) conclusion of study
Play Video | + Favorites
Resveratrol improves postmenopausal wellbeing
Creator: Rachel Wong and Jay Jay Thaung Zaw
Duration: 04:26
The RESveratrol for Healthy Ageing in Women (RESHAW) study examined the effects of 12-month resveratrol supplementation on health outcomes relevant to postmenopausal women such as cognitive function, mood, cerebrovascular function, cardiometabolic markers, bone health, wellbeing and physical function. This paper reports the one of the secondary outcomes of the RESHAW study. In this video, authors Rachel Wong and Jay Jay Thaung Zaw outline the findings on aspects of wellbeing following resveratrol supplementation in postmenopausal women.
Play Video | + Favorites
Migraine and Menopause: Introductory video
Creator:
Duration: 6:02
Brief summary and key points from article
Play Video | + Favorites
The Development of a Core Outcome Set for Menopausal Symptoms (COMMA)
Creator: Martha Hickey
Duration: 4:01
Description of what a core outcome set is, the process of development and the protocol for developing a core outcome set for menopausal symptoms
Play Video | + Favorites
Female Reproductive Health and Cognitive Function
Creator: Chia-Kuang Tsai
Duration: 3:47
This study highlighted the correlation between number of pregnancies and cognitive malfunction in postmenopausal females. Women with more pregnancies had poorer cognitive performance, especially those who had their last pregnancy after 28 years of age and less than 12 years of education. Giving birth early in life and adequate education may be beneficial to prevent or delay cognitive impairment.
Play Video | + Favorites
Is Hypertension or Diabetes During Pregnancy Related to More Vasomotor Symptoms in Midlife?
Creator: Yamnia I. Cortés
Duration: 3:23
In this video, Dr. Yamnia I. Cortés provides a summary of an investigation in the Study of Women’s Health Across the Nation, “Impact of nulliparity, hypertensive disorders of pregnancy, and gestational diabetes on vasomotor symptoms in midlife women.”
Play Video | + Favorites